Gut dysbiosis induces the development of depression-like behavior through abnormal synapse pruning in microglia-mediated by complement C3Original paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
Researchers examined whether gut dysbiosis drives depression-like behavior through complement C3 signaling and microglial synaptic pruning in mice.
How was it studied?
Mice underwent chronic unpredictable mild stress (CUMS) to induce depression-like behavior. Gut microbiota from CUMS mice were then transplanted into specific pathogen-free and germ-free recipient mice, and effects of antidepressants and fecal transplants from antidepressant-treated donors were also tested.
What did they find?
CUMS mice showed depression-like behavior and cognitive impairment alongside gut dysbiosis, with enrichment of Proteobacteria and elevated microbiota-derived lipopolysaccharides. Transplanting this microbiota into recipient mice reproduced the depression-like behavior, cognitive impairment, and increased complement C3/CR3 activation with abnormal microglial synaptic pruning in the prefrontal cortex. Antidepressants and microbiota transplants from treated donors reversed these behavioral and gut changes, inhibited the C3/CR3 pathway, and restored synapsin and postsynaptic density protein 95 levels.
Why it matters
The findings suggest gut dysbiosis can causally drive depression through a complement-mediated microglial pruning pathway, pointing to microbiota-targeted approaches as a potential route to treat depression.